Immunocore Holdings plc - American Depositary Shares — Liquidità (NASDAQ:IMCR)

Financials

Flusso di cassa derivante dalle attività operative ———2.94 M26.06 M-10.71 M -24.92 M Flussi di cassa derivanti dalle attività di investimento ———-5.42 M-355.13 M-16.34 M -21.82 M Liquidità derivante dalle attività di finanziamento ———34.35 M343.88 M12.37 M 10.48 M Liquidità libera ———2.94 M26.06 M-10.71 M -24.92 M

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

IMCR

Financials

Immunocore Holdings plc - American Depositary Shares

Notizie

FDA Grants Priority Review to SNY's Filing for Gaucher Disease Drug

TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study

CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up

AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication

Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy

FDA Extends Review Time for AZN's Camizestrant Combo in Breast Cancer

Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?

AZN, Daiichi's Enhertu Gets Positive CHMP Opinion for Solid Tumors

AZN, Daiichi's Datroway Wins FDA Nod for Expanded Use in Breast Cancer

AGIO's Pyrukynd Gets Approval for Thalassemia in Europe

GILD Scores FDA Win for HDV Drug, CHMP Backs Trodelvy

CHMP Backs EU Approval of Novo Nordisk's Wegovy Pill for Obesity